431 related articles for article (PubMed ID: 22072025)
1. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.
Manolova I; Gerenova J; Ivanova M
Eur Cytokine Netw; 2013 Mar; 24(1):69-74. PubMed ID: 23614931
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
Sayed SK; Galal SH; Herdan OM; Mahran AM
Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349
[TBL] [Abstract][Full Text] [Related]
6. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
Xing Q; Su H; Cui J; Wang B
Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
[TBL] [Abstract][Full Text] [Related]
7. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
[TBL] [Abstract][Full Text] [Related]
9. Soluble E-cadherin in systemic lupus erythematosus.
Jin T; Almehed K; Zhu Y; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2013 Oct; 40(10):1677-82. PubMed ID: 23996289
[TBL] [Abstract][Full Text] [Related]
10. Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients.
Rashad NM; El-Shabrawy RM; Said D; El-Shabrawy SM; Emad G
Egypt J Immunol; 2019 Jan; 26(1):31-42. PubMed ID: 31332994
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
12. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytes from systemic lupus erythematosus patients display increased spreading on VCAM-1, an effect associated with active renal involvement.
Cheng Q; Hoi A; Hickey MJ; Morand EF
Lupus; 2012 May; 21(6):632-41. PubMed ID: 22345121
[TBL] [Abstract][Full Text] [Related]
15. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
[TBL] [Abstract][Full Text] [Related]
16. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
[TBL] [Abstract][Full Text] [Related]
17. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.
Yip J; Aghdassi E; Su J; Lou W; Reich H; Bargman J; Scholey J; Gladman DD; Urowitz MB; Fortin PR
J Rheumatol; 2010 Aug; 37(8):1667-72. PubMed ID: 20516026
[TBL] [Abstract][Full Text] [Related]
18. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
19. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
